Since our screen, in conjunction with our subsequent functional analysis of overall FGF signals, indicated a possible role for FGF9 signals in intestinal carcinoma, we examined the relative expression levels of FGF9 in a set of 95 expression profiles of human colon cancer, comprising normal colon (4 profiles), advanced colon carcinoma (staged T3/4 by International Union Against Cancer (UICC) criteria; 41 profiles), and metastases to lymph nodes, liver and lung (50 profiles) [46]. This evidence concerns the gene FGF9 and colonic neoplasm.